Erweiterte Suche

Derzeit ist Sergey Aleksandrovich Cherkashin Executive Vice President-Business Performance bei Polymetal International Plc und Executive Vice President-Business Performance bei Polymetal JSC (einer Tochtergesellschaft von Polymetal International Plc). Zuvor war er stellvertretender CEO-Entwicklung bei Volgograd Dairy Plant, Verkaufsdirektor für Ulyanovsk Automobile Plant LLC, Chief Financial Officer von Timashevsk Dairy Plant und Berater bei A.T. Kearney. Sergey Aleksandrovich Cherkashin erwarb einen Bachelor-Abschluss am Moskauer Institut für Physik und Technologie.

Pavel Alexandrovich Cherkashin is the founder of Mindrock LLC (founded in 2017) where he currently holds the title of Managing Partner.
He is also the founder of Actis LLP (founded in 1997) where he held the title of CEO from 1997 to 2000.
Additionally, he founded Sputnik Labs OOO (founded in 2001) and held the title of Director from 2001 to 2004.
Dr. Cherkashin is also the founder of Global Venture Alliance Capital (founded in 2013) where he currently holds the title of Managing Partner.
Dr. Cherkashin is also the founder of AdWatch, Gdeslon LLC.
Dr. Cherkashin's former job(s) include being the CEO of 906 World Cultural Center from 2015 to 2021, Country Manager-Russia & CIS at Adobe, Inc. from 2006 to 2009, General Manager, Consumer & Online-Russia at Microsoft Corp.
from 2009 to 2011, Managing Partner at GVA Capital from 2015 to 2021, and Country Manager-Russia & CIS at Siebel Systems, Inc. from 2004 to 2006.
Dr. Cherkashin's education history includes being an undergraduate at Moscow State University Lomonosov.

Vasily Vladimirovich Cherkashin has a current job as Director at Rosseti Siberia PJSC.

Vasiliy Vladimirovich Cherkashin is currently the Strategic Director at Siberian Generating Co. LLC since 2011.
Prior to this, he worked as a Director at Rosseti Siberia PJSC.

Sergey V.
Sheleg is Chief Research Scientist of Alcor Life Extension Foundation.
Prior to joining Alcor Life Extension Foundation in 2005, he was a Research Associate of the N.N.
Alexandrov Research Institute of Oncology and Medical Radiology.
Dr. Sheleg became a Postdoctoral Fellow at the Center for Biologics Evaluation and Research of the U.S.
Food & Drug Administration in 2002.
Previously, he held a Visiting Fellow at National Institutes of Health from 2004 to 2005.
Dr. Sheleg received an MD from the Belarus State Medical University in 1994 and a PhD in Oncology from the N.N.
Alexandrov Research Institute of Oncology and Medical Radiology in 2002.